SPONSOR
AC Camargo Cancer Center
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Rectal Cancer, AdenocarcinomaNeuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2Neuroendocrine Tumor of PancreasNeuroendocrine Tumor of the LungNeuroendocrine Tumor CarcinoidCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Colon Cancer
NCT06793137 Phase 2
Recruiting
Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Rectal Cancer, Adenocarcinoma
NCT06472388 Phase 2
Recruiting
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Neuroendocrine Tumors
NCT07268846
Recruiting
Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery
Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
NCT07285356
Recruiting
Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
Colon Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology